JP2006232716A - Externally applied agent - Google Patents

Externally applied agent Download PDF

Info

Publication number
JP2006232716A
JP2006232716A JP2005048678A JP2005048678A JP2006232716A JP 2006232716 A JP2006232716 A JP 2006232716A JP 2005048678 A JP2005048678 A JP 2005048678A JP 2005048678 A JP2005048678 A JP 2005048678A JP 2006232716 A JP2006232716 A JP 2006232716A
Authority
JP
Japan
Prior art keywords
skin
hinokitiol
externally applied
wet
external preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005048678A
Other languages
Japanese (ja)
Inventor
Takehiko Abe
武彦 阿部
Shigeo Ebizuka
重夫 海老塚
Hiroyuki Ouchi
宏之 大内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HINOKI SHINYAKU KK
Original Assignee
HINOKI SHINYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HINOKI SHINYAKU KK filed Critical HINOKI SHINYAKU KK
Priority to JP2005048678A priority Critical patent/JP2006232716A/en
Publication of JP2006232716A publication Critical patent/JP2006232716A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an externally applied agent durably expressing excellent antimicrobial activities, preventing diseases caused by abnormal growth of normal microbes on the skin and unpleasant body odors and keeping the skin in a healthy state. <P>SOLUTION: The externally applied agent comprises compounding a composite compound prepared by mixing at least one compound selected from hinokitiol, its salts and its derivatives with ceramics, silicate compounds, cellulose or the like, and prevents bacteria, fungi and the like normally presenting in the skin by applying the agent to a part of the wet skin or the skin with plenty of water, diseases of mucous membranes and the like. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

この発明は、細菌、真菌等が関与し湿潤あるいは水分の多い部位の皮膚、粘膜のトラブル等に適応する、持続的に効果を発揮する外用剤に係わる。   The present invention relates to an external preparation that exerts a continuous effect and is adapted to troubles of skin, mucous membranes, etc. in wet or wet sites involving bacteria, fungi and the like.

皮膚に生息し高頻度にみられ病原性を持たない細菌等を皮膚常在菌といい、健常な皮膚では複数の常在菌が生態系(スキンフローラ)を形成して共生状態にあり有益必要な存在となっている。しかし、皮膚の状態変化や環境変化等により常在菌の生態系バランスが崩れ、細菌の増殖が生じると、さまざまな皮膚疾患等の要因となる。たとえばカンジダ等の関与で悪化するおむつ皮膚炎(おむつかぶれ)、白癬菌による水虫などがある。また、汗臭、腋臭あるいは加齢臭などの体臭の発生には、いずれも皮膚常在菌が関与して汗、皮脂、老化角質(垢)等が分解等されることに起因すると考えられている。   Bacteria, etc. that inhabit the skin and are frequently observed and have no pathogenicity are called skin resident bacteria. In healthy skin, multiple resident bacteria form an ecosystem (skin flora) and are in a symbiotic state and need to be beneficial. It has become a presence. However, when the ecological balance of the resident bacteria is disrupted due to changes in the state of the skin, environmental changes, etc., and bacterial growth occurs, it causes various skin diseases and the like. For example, there are diaper dermatitis (diaper rash) worsened by the involvement of Candida, etc., and athlete's foot caused by ringworm. In addition, the occurrence of body odors such as sweat odor, scent odor or aging odor is considered to be caused by the decomposition of sweat, sebum, aging keratin (skin), etc. due to the presence of skin resident bacteria. Yes.

このため、これら皮膚に生息する常在菌のバランスが崩れ、カンジダや白癬菌が増殖したために起こる皮膚疾患に対しては、ミコナゾールなどのイミダゾール系の抗真菌剤等が用いられ、また体臭に対しては、ハロカルバンや塩化ベンザルコニウムなどの抗菌剤等が用いられている。   For this reason, imidazole antifungal agents such as miconazole are used for skin diseases caused by the disruption of the balance of the resident bacteria that inhabit these skins and the growth of Candida and ringworm bacteria. For example, antibacterial agents such as halocarban and benzalkonium chloride are used.

常在菌の異常増殖に従来適用されてきた外用剤は、いずれも皮膚刺激や持続的な効果等について改善の余地がある。しかも、細菌の繁殖は湿潤したあるいは水分の多い皮膚で起こりやすいため、高温多湿の夏期で、特に汗が貯留しやすい部位で発症しやすく、また体臭も生じやすい。しかしながら、おむつ皮膚炎(おむつかぶれ)のお尻、水虫ができやすい足や体臭発生に関わりの深い腋の下等の部位は、下着、靴下あるいは皮膚等と擦れ合うことになり、貼付剤等の持続的効果に優れた剤型の適応が難しかった。そこで、持続的に優れた抗菌作用等を発揮させ、皮膚を健全な状態に維持できる外用剤の開発が望まれていた。   Any of the external preparations conventionally applied to abnormal growth of resident bacteria has room for improvement in terms of skin irritation and sustained effects. In addition, since bacterial growth is likely to occur on moist or wet skin, it is more likely to develop in hot and humid summers, particularly at sites where sweat is likely to accumulate, and body odor is also likely to occur. However, the butt of diaper dermatitis (diaper rash), feet that are susceptible to athlete's foot, and underarms that are deeply involved in the generation of body odor will rub against underwear, socks or skin, etc. It was difficult to apply a dosage form excellent in Therefore, it has been desired to develop an external preparation that can continuously exhibit excellent antibacterial action and the like and can maintain the skin in a healthy state.

一方、ヒノキチオールは、青森ヒバ油、台湾ヒノキ油等からの抽出、精製及び化学合成によって得られる物質で、優れた抗菌、殺菌作用に加え、消炎作用や細胞賦活作用を有し、しかも皮膚、粘膜に対する刺激性が低いことから医療の分野では歯槽膿漏や白癬症、円形脱毛症などの外用医薬品、育毛剤、薬用化粧品等に利用されている。近年では、院内感染で問題になったMRSA(メチシリン耐性黄色ぶどう球菌)への抗菌性も確認され、抗生物質などで問題となっている薬剤耐性菌の発現をみない天然由来の物質として注目されている。しかしながら、ヒノキチオールは皮膚、粘膜への吸収性が高いため、特に湿潤あるいは水分の多い皮膚部位で、通常用いられている、液剤、乳剤あるいは軟膏剤等で持続的に抗菌作用等を発揮させることは困難であった。   On the other hand, hinokitiol is a substance obtained by extraction, purification and chemical synthesis from Aomori hiba oil, Taiwan cypress oil, etc., and has an antibacterial and bactericidal action, as well as an anti-inflammatory action and a cell activation action. In the field of medicine, it is used for external medicines such as alveolar pyorrhea, ringworm, alopecia areata, hair restorer, medicinal cosmetics and the like. In recent years, antibacterial activity against MRSA (methicillin-resistant Staphylococcus aureus), which has been a problem in nosocomial infections, has also been confirmed, and has attracted attention as a naturally-occurring substance that does not show the expression of drug-resistant bacteria that are problematic with antibiotics. ing. However, since hinokitiol is highly absorbed into the skin and mucous membranes, it is not possible to exert its antibacterial action continuously with liquids, emulsions, ointments, etc., which are usually used especially in wet or moist skin areas. It was difficult.

そこで前記目的を達成するために本発明者らは湿潤したあるいは水分の多い皮膚、粘膜の部位に適応し持続的な抗菌作用等を発現する製剤を得るべく鋭意研究を重ねた結果、ヒノキチオール及びその塩及びその誘導体から選ばれる少なくとも1種の化合物とセラミックス、ケイ酸化合物又はセルロース等との混成により得られた複合物が、湿潤したあるいは水分の多い皮膚、粘膜の部位でのカンジダや白癬菌の増殖による皮膚、粘膜の疾患等や体臭に対して持続的に有効な抗菌作用等を発揮することを見出し、本発明を完成するに至った。   Therefore, in order to achieve the above-mentioned object, the present inventors have conducted intensive research to obtain a preparation that can be applied to moist or moist skin or mucous membrane sites and develop a continuous antibacterial action. As a result, hinokitiol and its A compound obtained by mixing at least one compound selected from salts and derivatives thereof with ceramics, silicic acid compounds, cellulose, or the like is used for the treatment of Candida and ringworm fungus in wet or wet skin and mucous membranes. The inventors have found that the antibacterial action and the like that are effectively effective against skin and mucous membrane diseases and body odor caused by proliferation have been found, and have completed the present invention.

本発明においてヒノキチオールとの複合物を形成するセラミックスとしては、粘土鉱物に限らずカルシウム化合物、マグネシウム化合物、アルミニウム化合物、チタン化合物、亜鉛化合物等の無機粉体をあげることができる。ケイ酸化合物としては、二酸化ケイ素、特に純度の高いシリカゲルが好ましい。さらに、セルロース、シルク、デンプン等から誘導される有機粉体を利用することもできる。また、いずれの粉体も多孔性粒子であることがより好ましい。   In the present invention, ceramics forming a composite with hinokitiol are not limited to clay minerals, and include inorganic powders such as calcium compounds, magnesium compounds, aluminum compounds, titanium compounds, and zinc compounds. As the silicic acid compound, silicon dioxide, particularly silica gel with high purity is preferable. Furthermore, organic powders derived from cellulose, silk, starch and the like can be used. Moreover, it is more preferable that any powder is a porous particle.

本発明で用いるヒノキチオール及びその塩及びその誘導体から選ばれる少なくとも1種の化合物の配合量については限定しないが、0.001〜5.0重量%が好ましく、さらには0.01〜2.0重量%がより好ましい。   The amount of at least one compound selected from hinokitiol and its salts and derivatives used in the present invention is not limited, but is preferably 0.001 to 5.0% by weight, more preferably 0.01 to 2.0% by weight. % Is more preferable.

本発明による外用剤としては限定しないが、好ましくは散剤で、通常使用される製剤用担体、賦型剤、その他の添加剤を配合することができ、その製剤化は常法により行うことができる。 Although it does not limit as an external preparation by this invention, Preferably it is a powder and can mix | blend the support | carrier for a formulation normally used, an excipient | filler, and another additive, The formulation can be performed by a conventional method. .

ヒノキチオールとセラミックス、ケイ酸化合物あるいはセルロース等との混成法は、常法により行うことができる。例えば、ヒノキチオールの水溶液にセラミックスを懸濁させ、その懸濁物を乾燥させて得ることができる。この際、加熱処理により乾燥することで複合物を製剤に配合し皮膚、粘膜に適応したときに、より徐放性を高めることができる。   The hybrid method of hinokitiol and ceramics, silicate compound or cellulose can be performed by a conventional method. For example, it can be obtained by suspending ceramics in an aqueous solution of hinokitiol and drying the suspension. At this time, when the composite is blended into the preparation and applied to the skin and mucous membrane by drying by heat treatment, the sustained release can be further enhanced.

本発明により、カンジダや白癬菌等に起因する皮膚、粘膜の疾患や体臭に対し、持続性に優れた有効性の高いヒノキチオール配合の外用剤を得ることが可能となる。   INDUSTRIAL APPLICABILITY According to the present invention, it is possible to obtain a highly effective external preparation containing hinokitiol which is excellent in sustainability against skin and mucous membrane diseases and body odor caused by Candida, ringworm, etc.

次に実施例を挙げて、本発明をさらに詳細に説明するが、本発明はこれらに限定されるものではない。   EXAMPLES Next, although an Example is given and this invention is demonstrated further in detail, this invention is not limited to these.

実施例1(パウダー)
ヒノキチオールを多孔性シリカゲルに付着させた複合物(ヒノキチオール0.5%含有)40%、タルク45%、ラウロイルリジン10%、シルクパウダー5%を均一に混和して容器に充填し、外用剤とする。この外用剤を比較的湿潤したあるいは水分の多い皮膚の部位に適用する。
Example 1 (powder)
40% composite containing hinokitiol attached to porous silica gel (containing 0.5% hinokitiol), 45% talc, 10% lauroyllysine and 5% silk powder are uniformly mixed and filled into a container to obtain an external preparation. . This external preparation is applied to a relatively moist or wet skin site.

実施例2(パウダースプレー)
ヒノキチオールを球状セルロースに含有させた複合物(ヒノキチオール1%含有)5%、ラウロイルリジン5%、メチルシクロポリシロキサン2%、噴射剤(液化石油ガス若しくは窒素ガス)88%を加えてスプレー容器に充填し外用剤とする。この外用剤を比較的湿潤したあるいは水分の多い皮膚の部位に適用する。
Example 2 (powder spray)
Add 5% composite containing hinokitiol in spherical cellulose (containing 1% hinokitiol), 5% lauroyllysine, 2% methylcyclopolysiloxane, 88% propellant (liquefied petroleum gas or nitrogen gas) and fill into spray container It should be used as an external preparation. This external preparation is applied to a relatively moist or wet skin site.

比較例1(ローション)
ヒノキチオール0.2%、ポリオキシエチレン硬化ヒマシ油0.5%、エタノール5%を加温混和し、これに精製水94.3%を加えて均一混和して容器に充填する。
Comparative Example 1 (Lotion)
Add 0.2% hinokitiol, 0.5% polyoxyethylene hydrogenated castor oil, and 5% ethanol, and add 94.3% purified water to this, mix uniformly, and fill into a container.

比較例2(パウダースプレー)
球状セルロース5%、ラウロイルリジン5%、メチルシクロポリシロキサン2%、噴射剤(液化石油ガス若しくは窒素ガス)88%を加えてスプレー容器に充填し外用剤とする。
Comparative Example 2 (powder spray)
Add 5% spherical cellulose, 5% lauroyl lysine, 2% methylcyclopolysiloxane, 88% propellant (liquefied petroleum gas or nitrogen gas) and fill into a spray container to make an external preparation.

(おむつ皮膚炎改善効果、水虫改善効果)
実施例1、実施例2及び比較例1、比較例2の外用剤について、それぞれおむつ皮膚炎(おむつかぶれ)で悩む小児20名、及び水虫(白癬)を有する成人20名を一群として、1ヶ月間の連続使用試験を実施し、それぞれの症状についての改善効果を評価した。結果は、表1、表2に示したとおりであるが、おむつ皮膚炎、水虫の改善に対して非常に良好な結果が得られた。
(Diaper dermatitis improvement effect, athlete's foot improvement effect)
About 1 external medicine of Example 1, Example 2, Comparative Example 1, and Comparative Example 2, 20 children suffering from diaper dermatitis (diaper rash) and 20 adults having athlete's foot (rinchoderma) respectively A continuous use test was conducted to evaluate the improvement effect for each symptom. The results are as shown in Tables 1 and 2, but very good results were obtained for the improvement of diaper dermatitis and athlete's foot.

Figure 2006232716
Figure 2006232716

Figure 2006232716
Figure 2006232716

(体臭防止効果)
実施例2及び比較例2の外用剤について、体臭が気になる成人10名を被験者とし、それぞれの外用剤を毎日入浴後に(特定した側の)片腋のみに塗布し1週間の連続使用試験を実施後、専門パネラーによる官能評価により体臭防止効果を判定した。結果は、表3に示したとおりであるが、体臭の防止に対して非常に良好な結果が得られた。
(Body odor prevention effect)
For the topical preparations of Example 2 and Comparative Example 2, 10 adults whose body odor is anxious are used as subjects, and each topical preparation is applied to only one side (on the specified side) after taking a bath every day, and a continuous use test for one week. After carrying out, the body odor prevention effect was determined by sensory evaluation by a specialized panelist. The results are as shown in Table 3, but very good results were obtained for the prevention of body odor.

Figure 2006232716
Figure 2006232716

本発明による持続性に優れた有効性の高いヒノキチオール配合の外用剤を特に水分の多い部位の皮膚、粘膜の疾患等に適応することにより、皮膚常在菌を健全な状態に保ち、カンジダや白癬菌等の異常繁殖による皮膚・粘膜の疾患や体臭を防ぐことができるので、新たな外用剤の需要が見込まれる。
By applying the external preparation containing hinokitiol having excellent durability and high durability according to the present invention to diseases of skin and mucous membranes particularly in areas with high water content, normal skin bacteria are kept in a healthy state, and Candida and ringworm Since it can prevent skin and mucous membrane diseases and body odor due to abnormal growth of bacteria and the like, demand for new external preparations is expected.

Claims (2)

ヒノキチオール及びその塩及びその誘導体から選ばれる少なくとも1種の化合物を含有し、製剤から化合物を徐々に放出させて抗菌効果を持続的に発揮させることにより、皮膚常在菌の異常増殖を防止することを特徴とする外用剤。   It contains at least one compound selected from hinokitiol and its salts and derivatives, and gradually releases the compound from the preparation to continuously exert its antibacterial effect, thereby preventing abnormal growth of resident skin bacterium. An external preparation characterized by ヒノキチオール及びその塩及びその誘導体から選ばれる少なくとも1種の化合物とセラミックス、ケイ酸化合物又はセルロース等と混成することにより得られる複合物を配合した、湿潤あるいは水分の多い部位の皮膚、粘膜の疾患等に適応して細菌、真菌の異常増殖を防止する外用剤。
Skin and mucous membrane diseases in wet or moist areas containing at least one compound selected from hinokitiol and its salts and derivatives and composites obtained by mixing with ceramics, silicate compounds or cellulose, etc. An external preparation that is adapted to prevent abnormal growth of bacteria and fungi.
JP2005048678A 2005-02-24 2005-02-24 Externally applied agent Pending JP2006232716A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005048678A JP2006232716A (en) 2005-02-24 2005-02-24 Externally applied agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005048678A JP2006232716A (en) 2005-02-24 2005-02-24 Externally applied agent

Publications (1)

Publication Number Publication Date
JP2006232716A true JP2006232716A (en) 2006-09-07

Family

ID=37040770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005048678A Pending JP2006232716A (en) 2005-02-24 2005-02-24 Externally applied agent

Country Status (1)

Country Link
JP (1) JP2006232716A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011074045A (en) * 2009-10-02 2011-04-14 Seems Inc Aqueous solution of hinokitiol and method for producing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0457836A (en) * 1990-06-27 1992-02-25 Fukui Kagaku Kogyo Kk Spherical porous cellulose particle comprising chitin or deacetylated chitin and cellulose, and preparation thereof
JPH10265408A (en) * 1997-03-25 1998-10-06 Lion Corp Sterilizer composition
JPH11151438A (en) * 1997-11-20 1999-06-08 National Institute Of Sericultual And Entomological Science Adsorptive body/gradually releasing body consisting of biopolymer, and its production and adsorption method
JP2003523379A (en) * 2000-02-21 2003-08-05 オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション Controlled release ceramic particles, their compositions, methods of preparation and use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0457836A (en) * 1990-06-27 1992-02-25 Fukui Kagaku Kogyo Kk Spherical porous cellulose particle comprising chitin or deacetylated chitin and cellulose, and preparation thereof
JPH10265408A (en) * 1997-03-25 1998-10-06 Lion Corp Sterilizer composition
JPH11151438A (en) * 1997-11-20 1999-06-08 National Institute Of Sericultual And Entomological Science Adsorptive body/gradually releasing body consisting of biopolymer, and its production and adsorption method
JP2003523379A (en) * 2000-02-21 2003-08-05 オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション Controlled release ceramic particles, their compositions, methods of preparation and use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011074045A (en) * 2009-10-02 2011-04-14 Seems Inc Aqueous solution of hinokitiol and method for producing the same

Similar Documents

Publication Publication Date Title
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
ES2534843T3 (en) Antimicrobial and anti-acne formulations
US20130209386A1 (en) New uses
ATE487720T1 (en) 5,6,7,8-TETRAHYDROPTERIDINE DERIVATIVES AS HSP90 INHIBITORS
JP2020164548A (en) Composition containing meso-2,3-butanediol
JP2007523137A5 (en)
JP2015535298A (en) Powder composition for disinfection of dairy nipples
US5453266A (en) Powdered body deodorant composition
JP2006232716A (en) Externally applied agent
JP4666938B2 (en) Plant antibacterial composition
EP2654746B1 (en) Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt
CA2972238C (en) Personal care composition with zinc phosphate active
JP2007186465A (en) Antibacterial agent against bacteria causing armpit smell
CN116600642A (en) Sterile, skin-tolerant, care and moisturizing formulation for application to skin
KR101087027B1 (en) Skin Cosmetic Composition Containing Antiperspirant Agents With Improved Stability
BR112012009730A2 (en) use of menthyl substances as antibacterial, antimycotic or antiviral active substances
JP4824553B2 (en) Method for inhibiting growth of antibiotic-resistant bacteria by using pentane-1,5-diol
JP2017193504A (en) Deodorizing cosmetic
FR2975907A1 (en) Composition, useful for podology, comprises antiperspirant agent, adhesion agent, sliding agent, colloidal silica, and optionally antibacterial agent and/or antifungal agent in conjunction or mixture with excipient or inert carrier
JP2018052891A (en) Liniment for controlling resident skin bacteria
EP3471696A1 (en) Hand sanitizing composition
RU2014120382A (en) NEW COMPOSITION
JPS63215618A (en) Prevention of body odor
JP2021046381A (en) Antiperspirant composition
JP2020183358A (en) Cold sensation-imparting antibacterial deodorant

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100409

A02 Decision of refusal

Effective date: 20100728

Free format text: JAPANESE INTERMEDIATE CODE: A02